Dr.Garg's lab efforts are targeted to win the human fight against Trypanosoma cruzi that causes Chagasic cardiomyopathy.Chagas disease is a major public health threat in Latin America and Mexico, and recognized as an emerging infectious disease in the U.S.Her ongoing translational research with multiple international collaborations focuses on identifying the potential vaccine candidates, and using these candidates to develop multi-component vaccine(s) that provide protection against different T.cruzi strains in multiple animal hosts and humans.Working with young students and scientists in the lab, Dr.Garg utilizes innovative approaches to understand the pathomechanisms of oxidative stress in progressive Chagas disease, and develop adjunct therapies that can prevent or arrest the chronic heart failure.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.